Literature DB >> 13975085

Human assay of electrolyte-active steroids and their antagonists.

E J ROSS.   

Abstract

Entities:  

Keywords:  ALDOSTERONE; FLUDROCORTISONE; POTASSIUM; PTERINS; SODIUM; SPIRONOLACTONE

Mesh：

Substances：

Year:  1962        PMID： 13975085

Source DB:  PubMed          Journal:  Clin Sci        ISSN： 0009-9287            Impact factor:   6.124


× No keyword cloud information.
  13 in total

1.  Bioassay of aldosterone antagonists in normal human subjects: a relationship between the level of plasma uric acid before treatment and apparent drug responses.

Authors:  L E Ramsay; P Hessian; M J Tidd
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

2.  Antagonism of fludrocortisone by spironolactone and canrenone.

Authors:  G J Huston; P Turner
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

3.  Canrenone--the principal active metabolite of spironolactone?

Authors:  L E Ramsay; J R Shelton; D Wilkinson; M J Tidd
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

4.  A comparison of some extra-renal effects of spironolactone and canrenone.

Authors:  G J Huston; E A Al-Dujaili
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

5.  Possible protective action of antialdosterone compounds in myocardial necrosis in rats.

Authors:  L R Moudgil
Journal:  Br J Pharmacol       Date:  1969-03       Impact factor: 8.739

6.  Paradoxical potassium excretion in response to aldosterone antagonists.

Authors:  L E Ramsay; I R Harrison; J R Shelton; M J Tidd
Journal:  Eur J Clin Pharmacol       Date:  1977-01-03       Impact factor: 2.953

7.  Relative potency and structure activity relationships of aldosterone antagonists in healthy man: correlation with animal experience.

Authors:  G T McInnes; J R Shelton; L E Ramsay; I R Harrison; M J Asbury; J M Clarke; R M Perkins; G R Venning
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

8.  Improved method for comparative evaluation of aldosterone antagonists in healthy man.

Authors:  J Casals-Stenzel; J Schmalbach; W Losert
Journal:  Eur J Clin Pharmacol       Date:  1977-12-02       Impact factor: 2.953

9.  Spironolactone dose-response relationships in healthy subjects.

Authors:  G T McInnes; R M Perkins; J R Shelton; I R Harrison
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

10.  The pharmacodynamics of single doses of prorenoate potasssium and spironolactone in fludrocortisone treated normal subjects.

Authors:  L E Ramsay; J R Shelton; M J Tidd
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.